Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8200417rdf:typepubmed:Citationlld:pubmed
pubmed-article:8200417lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8200417lifeskim:mentionsumls-concept:C0026845lld:lifeskim
pubmed-article:8200417lifeskim:mentionsumls-concept:C0018792lld:lifeskim
pubmed-article:8200417lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:8200417lifeskim:mentionsumls-concept:C0205160lld:lifeskim
pubmed-article:8200417lifeskim:mentionsumls-concept:C1705490lld:lifeskim
pubmed-article:8200417lifeskim:mentionsumls-concept:C0071174lld:lifeskim
pubmed-article:8200417lifeskim:mentionsumls-concept:C0140805lld:lifeskim
pubmed-article:8200417pubmed:issue3lld:pubmed
pubmed-article:8200417pubmed:dateCreated1994-7-5lld:pubmed
pubmed-article:8200417pubmed:abstractTextThe effects of Ro 5-4864, a peripheral benzodiazepine receptor agonist (9 x 10(-6) M and 9 x 10(-5) M) and of PK 11195, a peripheral benzodiazepine receptor antagonist (3 x 10(-6) M and 3 x 10(-5) M), alone or together, on contraction parameters of human atrial muscle strips were studied. Atrial muscle strips were obtained from patients undergoing cardiac surgery. The strips were suspended in Krebs-Henseleit solution at 36.8 +/- 0.2 degrees C, connected to an isometric force transducer and then stimulated at 15 V above threshold and paced at 1.5 Hz. Ro 5-4864 at its higher concentration, alone or mixed with PK 11195 at both concentrations, depressed the contraction amplitude to 80% of the control value (P < 0.05). In conclusion, Ro 5-4864 had a small but significant depressant effect on the contraction amplitude of human atrial strips. Surprisingly, this effect was not reversed by the peripheral benzodiazepine receptor antagonist PK 11195.lld:pubmed
pubmed-article:8200417pubmed:languageenglld:pubmed
pubmed-article:8200417pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8200417pubmed:citationSubsetIMlld:pubmed
pubmed-article:8200417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8200417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8200417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8200417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8200417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8200417pubmed:statusMEDLINElld:pubmed
pubmed-article:8200417pubmed:monthMarlld:pubmed
pubmed-article:8200417pubmed:issn0014-2999lld:pubmed
pubmed-article:8200417pubmed:authorpubmed-author:BarakYYlld:pubmed
pubmed-article:8200417pubmed:authorpubmed-author:GellerEElld:pubmed
pubmed-article:8200417pubmed:authorpubmed-author:GavishMMlld:pubmed
pubmed-article:8200417pubmed:authorpubmed-author:VidneBBlld:pubmed
pubmed-article:8200417pubmed:authorpubmed-author:ShandPPlld:pubmed
pubmed-article:8200417pubmed:authorpubmed-author:HochhauserEElld:pubmed
pubmed-article:8200417pubmed:authorpubmed-author:HalpernPPlld:pubmed
pubmed-article:8200417pubmed:authorpubmed-author:YakirevichVVlld:pubmed
pubmed-article:8200417pubmed:authorpubmed-author:HasharoniAAlld:pubmed
pubmed-article:8200417pubmed:issnTypePrintlld:pubmed
pubmed-article:8200417pubmed:day3lld:pubmed
pubmed-article:8200417pubmed:volume253lld:pubmed
pubmed-article:8200417pubmed:ownerNLMlld:pubmed
pubmed-article:8200417pubmed:authorsCompleteYlld:pubmed
pubmed-article:8200417pubmed:pagination231-6lld:pubmed
pubmed-article:8200417pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:8200417pubmed:meshHeadingpubmed-meshheading:8200417-...lld:pubmed
pubmed-article:8200417pubmed:meshHeadingpubmed-meshheading:8200417-...lld:pubmed
pubmed-article:8200417pubmed:meshHeadingpubmed-meshheading:8200417-...lld:pubmed
pubmed-article:8200417pubmed:meshHeadingpubmed-meshheading:8200417-...lld:pubmed
pubmed-article:8200417pubmed:meshHeadingpubmed-meshheading:8200417-...lld:pubmed
pubmed-article:8200417pubmed:meshHeadingpubmed-meshheading:8200417-...lld:pubmed
pubmed-article:8200417pubmed:meshHeadingpubmed-meshheading:8200417-...lld:pubmed
pubmed-article:8200417pubmed:meshHeadingpubmed-meshheading:8200417-...lld:pubmed
pubmed-article:8200417pubmed:meshHeadingpubmed-meshheading:8200417-...lld:pubmed
pubmed-article:8200417pubmed:meshHeadingpubmed-meshheading:8200417-...lld:pubmed
pubmed-article:8200417pubmed:meshHeadingpubmed-meshheading:8200417-...lld:pubmed
pubmed-article:8200417pubmed:meshHeadingpubmed-meshheading:8200417-...lld:pubmed
pubmed-article:8200417pubmed:year1994lld:pubmed
pubmed-article:8200417pubmed:articleTitleRo 5-4864 has a negative inotropic effect on human atrial muscle strips that is not antagonized by PK 11195.lld:pubmed
pubmed-article:8200417pubmed:affiliationPediatric Division, Soroka Medical Center, Beersheba, Israel.lld:pubmed
pubmed-article:8200417pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8200417pubmed:publicationTypeIn Vitrolld:pubmed